Current treatment options in mRCC

Bookmark and Share
Published: 23 Sep 2014
Views: 3123
Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA

Dr Hutson gives an overview of the current treatment options available for metastatic renal cell carcinoma (mRCC) and stresses the importance of choosing an appropriate first-line treatment.

GlaxoSmithKline fully provided for the costs of this symposium, honoraria for the chairs & speakers and provided input into the symposium agenda/content.